CRISPR技術市場レポート：2031年までの動向、予測、競合分析

世界のCRISPR（クラスター化等間隔短回文反復）技術市場の将来は、製薬・バイオテクノロジー企業や学術・研究機関市場に機会があり、有望視されています。世界のCRISPR技術市場は、2025年から2031年までのCAGRが23.4%で、2031年までに推定51億米ドルに達すると予想されます。この市場の主な促進要因は、CRISPR技術に対する政府からの投資の増加、新しいワクチンの採用と遺伝性疾患の治療の増加です。

• Lucintel社の予測では、製品タイプでは、予測期間中、製品がより大きなセグメントであり続けます。
• 最終用途別では、製薬・バイオテクノロジー企業が引き続き大きなセグメントとなります。
• 地域別では、北米が予測期間中最大の地域であることに変わりはないです。

CRISPR技術市場の戦略的成長機会

CRISPR技術市場は、特にこの多様な技術の戦略的応用を模索する企業にとって、大きな成長機会を提供します。このことから、利害関係者は、イノベーションを促進し、人間の健康、農業、バイオテクノロジーにおける差し迫った問題に対処するための拡張性のある手法に焦点を当てるべきです。

• 遺伝子治療の開発：遺伝性疾患を治療するためのCRISPRベースの遺伝子治療法の開発に投資することで、優れた代替治療法を生み出すことができます。この市場セグメントは、標的治療薬に対する患者の需要の増加により、成長する見込みです。
• 農業応用における革新：農業、特に干ばつや害虫に強い作物の開発において、CRISPRの役割を拡大できる可能性がかなりあります。この介入は、食糧不安と闘い、環境的に持続可能な農法を推進する上で極めて重要です。
• 研究機関との協力：大学や研究機関との共同プロジェクトは、CRISPR技術の利用と開発に関する新しいアイデアを生み出す可能性が高いです。このようなパートナーシップは、最新の科学的進歩へのアクセスを強化し、知識の共有を促進することができます。
• 倫理的ガバナンスの重視：一般大衆の賛同を確実に得るためには、CRISPRのような技術の使用を管理する専用のインフラを確立することが不可欠です。倫理的慣行を統合した公開会社は、規制や広報上の課題に直面する可能性が低くなります。
• AI主導のソリューションへの投資：人工知能と機械学習技術をCRISPRの設計と実施に応用することで、調査の質が向上します。この投資は遺伝子編集の精度と効率を向上させ、市場成長を促進します。

こうした戦略的成長機会は、CRISPRエコシステムにおけるイノベーションと市場拡大の大きな可能性を浮き彫りにします。これらの機会を活用することで、利害関係者は遺伝子研究とバイオテクノロジーの進歩に積極的に貢献すると思われます。

CRISPR技術市場の促進要因・課題

CRISPR技術市場にも、技術やその商業化、規制の問題、社会からの受容など、多くの市場促進要因・課題があります。市場の創出や投資を望むすべての人に関連する要因があります。これらの要因によって、市場力学を理解することが容易になりました。

CRISPR技術市場を牽引する要因は、以下の通り：

• 技術の変化：既存のCRISPR技術には、遺伝子編集プロセスの精度と効率を向上させる革新的な技術がいくつか存在し続けています。このような変化が、ヘルスケアや農業における様々な応用に向けたCRISPR技術への投資意欲を刺激しています。
• バイオ技術は今、より多くの資金を集めている：民間および政府からの資金提供は増加傾向にあり、CRISPR市場の製品開拓に新たな資金が投入されています。資金調達は新技術の導入とそれぞれの応用において重要な柱です。
• 患者に根ざした医療の増加：患者に特化した医療への治療アプローチの転換により、患者の治療のためのCRISPR関連医薬品の開発が急務となっています。これにより、遺伝子編集技術の限界が迫られ、遺伝子治療サービスの分野における競合に障壁が加わります。
• 遺伝子疾患に関する知識の増加：遺伝性疾患とその転帰についての理解が深まり、より高いレベルの治療法を求める患者が増加しています。このような理解は、治療法のさまざまな可能性が開発されるにつれて、CRISPR市場の開拓に拍車をかけています。
• 研究における世界の協力関係：CRISPRのさまざまな領域での進歩は、世界の研究センター間の協力により飛躍的に向上しています。こうした共同研究は、知識やリソースを共有・獲得する機会を提供し、イノベーションを後押しします。

クラスタード規則的間隔短縮回文反復技術市場における課題は、以下の通り：

• 倫理的懸念：遺伝子編集におけるCRISPRの使用は、遺伝子工学に関する懸念、長期的な影響、"デザイナーベビー"の創出など、重大な倫理問題を引き起こします。これらの懸念に対処することは、組織工学のような分野における将来の倫理的実践にとって極めて重要です。
• 知的所有権の問題：CRISPR市場は、複数の研究機関やバイオテクノロジー企業間の特許紛争に巻き込まれています。知的財産権をめぐる意見の対立は、協力を妨げ、創造性を阻害し、市場に課題をもたらす可能性があります。
• 技術的限界：CRISPR技術は非常に効果的ですが、オフターゲット効果や送達方法の制限といった課題に依然として直面しています。これらの欠点を取り除くことは、特に治療への応用には不可欠ですが、さらなる改善が必要です。

これらの課題は、CRISPR市場の成長と技術革新の速度にリスクをもたらします。法的、社会的、手続き上の障壁を克服することは、CRISPR技術の利点を最小限の関連リスクで実現するために不可欠です。

目次

第1章 エグゼクティブサマリー

第2章 世界のCRISPR技術市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2019年から2031年までの市場動向と予測分析

• マクロ経済動向（2019～2024年）と予測（2025～2031年）
• 世界のCRISPR技術市場動向（2019～2024）および予測（2025～2031）
• タイプ別：CRISPR技術の世界市場
  • 製品
  • サービス
  • その他
• 用途別：CRISPR技術の世界市場
  • 医薬品の発見と開発
  • 農業
  • その他
• 最終用途別：CRISPR技術の世界市場
  • 製薬・バイオテクノロジー企業
  • 学術調査機関
  • その他

第4章 2019年から2031年までの地域別市場動向と予測分析

• 地域別：世界のCRISPR技術市場
• 北米のCRISPR技術市場
• 欧州のCRISPR技術市場
• アジア太平洋のCRISPR技術市場
• その他地域のCRISPR技術市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • タイプ別：世界のCRISPR技術市場の成長機会
  • 用途別：世界のCRISPR技術市場の成長機会
  • 最終用途別：世界のCRISPR技術市場の成長機会
  • 地域別：世界のCRISPR技術市場の成長機会
• CRISPR技術の世界市場における新たな動向
• 戦略分析
  • 新製品開発
  • 世界のCRISPR技術市場の容量拡大
  • 世界のCRISPR技術市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 主要企業の企業プロファイル

• Thermo Fisher Scientific
• Merck
• Agilent Technologies
• Genscript Biotech
• CRISPR Therapeutics
• Editas Medicine
• Intellia Therapeutics
• Beam Therapeutics
• Caribou Biosciences
• Lonza

The future of the global clustered regularly interspaced short palindromic repeat technology market looks promising with opportunities in the pharmaceutical & biotechnology company and academic & research institute markets. The global clustered regularly interspaced short palindromic repeat technology market is expected to reach an estimated $5.1 billion by 2031 with a CAGR of 23.4% from 2025 to 2031. The major drivers for this market are the increasing investment from the government in CRISPR technology and the rising adoption of new vaccines and the treatment of genetic diseases.

• Lucintel forecasts that, within the type category, the product will remain the larger segment over the forecast period.
• Within the end use category, pharmaceutical & biotechnology companies will remain the larger segment.
• In terms of regions, North America will remain the largest region over the forecast period.

Gain Valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Clustered Regularly Interspaced Short Palindromic Repeat Technology Market

The clustered regularly interspaced short palindromic repeat technology market is presenting several emerging trends related to technological growth, regulatory changes, and increased usage of this technology across various sectors. These trends play a significant role in shaping the future of scientific inquiry, as well as the fields of molecular biology and biotechnology, particularly in antibiotic applications.

• Expansion of Therapeutic Applications: Scientists are increasingly working on the development of therapies for specific diseases, including CRISPR-based cancer immunotherapy. This is leading to clinical research progress through new investments that further the investigation, enabling better treatment results.
• Integration of AI and Machine Learning: The integration of AI and machine learning in CRISPR research is improving the accuracy of gene editing. These solutions allow scientists to forecast outcomes and enhance the effectiveness of editing techniques.
• Regulatory Harmonization: The gap in regulations is narrowing as countries establish rules for CRISPR and its applications. This is facilitating global engagement and accelerating the approval of CRISPR therapies.
• Focus on Sustainable Agriculture: CRISPR technologies are being used to develop crops that are more resistant to pests and diseases. This is crucial for food security and addressing the impacts of climate change.
• Ethical and Societal Discussions: There is increasing interest in discussing the ethical issues related to the advancement of CRISPR techniques. Public debates and legislative actions are evolving to mitigate risks associated with CRISPR technologies.

These new trends in biotechnology help prevent stagnation in the clustered regularly interspaced short palindromic repeat technology market by fostering new ideas, increasing efficiency, and ensuring responsible practices. As these trends evolve, stakeholders will need to manage them effectively to maximize the potential benefits of CRISPR technologies.

Recent Developments in the Clustered Regularly Interspaced Short Palindromic Repeat Technology Market

Recent developments in the clustered regularly interspaced short palindromic repeat technology market are characterized by expanding budgets for research and the development of cutting-edge technologies, as well as the introduction of new practices in both new and existing industries. These trends reflect a paradigm shift taking place in genetic research and biotechnology, marking a significant upward movement.

• Advancements in CRISPR Delivery Methods: New CRISPR component delivery systems are being developed to improve targeting and reduce undesired effects from off-target areas. Researchers are making advancements such as using lipid nanoparticles and viral vectors, which enhance gene editing effectiveness and lead to safer therapies.
• Clinical Trials for Genetic Therapies: The initiation of clinical trials for CRISPR-based therapies, such as those targeting sickle cell anemia and muscular dystrophy, represents significant progress. These trials are providing crucial data that could transform treatment approaches and accelerate the development of CRISPR therapeutic solutions.
• Increased Funding from Governments and Private Sectors: Both government agencies and private investors are making substantial investments in CRISPR research. This funding is driving the development of new technologies and applications, supporting creativity and innovation.
• Emergence of CRISPR in Agriculture: CRISPR is becoming more widely used in agriculture to develop stress-resistant modified plants. This advancement is key to improving food security and addressing the challenges posed by climate change.
• Global Collaborations in CRISPR Research: Researchers are increasingly engaging in international collaborations to tap into additional resources and improve their research efforts. These collaborations are helping push the boundaries of CRISPR technology development and the growth of research programs.

These recent developments are positively influencing the clustered regularly interspaced short palindromic repeat technology market, leading to better innovations and the expanded use of the technology. Moving forward, as the market continues to grow, ongoing research and collaboration will be essential to realizing the full potential of CRISPR technologies.

Strategic Growth Opportunities for Clustered Regularly Interspaced Short Palindromic Repeat Technology Market

The clustered regularly interspaced short palindromic repeat technology market offers significant opportunities for growth, particularly for those seeking to explore strategic applications of this diverse technology. In light of this, stakeholders should focus on scalable methods to foster innovation and address pressing issues in human health, agriculture, and biotechnology.

• Development of Gene Therapies: Investing in the development of CRISPR-based gene therapies for treating genetic disorders can yield excellent treatment alternatives. This market segment is poised for growth, driven by increasing patient demand for targeted therapeutics.
• Innovations in Agricultural Applications: There is considerable potential to expand CRISPR's role in agriculture, particularly in developing drought- and pest-resistant crops. This intervention is crucial for combating food insecurity and promoting environmentally sustainable farming practices.
• Collaboration with Research Institutions: Joint projects with universities and research-focused organizations are likely to generate new ideas for the use and development of CRISPR technologies. These partnerships can enhance access to the latest scientific advancements and facilitate knowledge sharing.
• Focus on Ethical Governance: To ensure public buy-in, it is essential to establish infrastructure dedicated to governing the use of technologies like CRISPR. Companies that integrate ethical practices are likely to face fewer regulatory and public relations challenges.
• Investment in AI-Driven Solutions: The application of artificial intelligence and machine learning technologies to CRISPR design and implementation will enhance research quality. This investment will improve the accuracy and efficiency of gene editing, thus driving market growth.

These strategic growth opportunities highlight the substantial potential for innovation and market expansion within the CRISPR ecosystem. By capitalizing on these opportunities, stakeholders will contribute positively to the advancement of genetic research and biotechnology.

Clustered Regularly Interspaced Short Palindromic Repeat Technology Market Driver and Challenges

The clustered regularly interspaced short palindromic repeat technology market too has a number of drivers and challenges among them being, technology and its commercialization, regulatory issues, and acceptance from society. There are factors that are relevant to all who wish to create or invest in the market. These factors have made it easier to understand the market dynamics.

The factors responsible for driving the clustered regularly interspaced short palindromic repeat technology market include:

• Changes in Technology: There continue to be several ongoing innovations related to existing CRISPR technologies that are improving the level of precision and efficiency of the gene editing process. These changes are triggering the appetite and investments in CRISPR technologies for various applications in healthcare and agriculture.
• Bio-Tech Now Attracts More Funding: Private and government funding is on the rise bringing new money into the development of products in the CRISPR market. Funding is an important pillar in the introduction of new technologies and their respective applications.
• Increase In Patient Rooted Medicine: The transformation of the treatment approach toward patient-specific medicine makes it exigent to develop CRISPR-related medicines for patients' treatment. This forces the limits of gene editing technology and adds barriers to competition in the area of genetic treatment services.
• Increase In The Knowledge Concerning Genetic Disorders: A rise in the comprehension of genetic disorders and their outcomes is leading more patients to look for higher levels of remedies. Such understanding is fueling the development of the CRISPR market as different possibilities for therapies are being developed.
• Global Collaboration in Research: Progress in the different domains of CRISPR is improving in leaps and bounds because of collaboration among global research centers. These collaborations provide opportunities for sharing and acquiring knowledge and resources thereby boosting innovation.

Challenges in the clustered regularly interspaced short palindromic repeat technology market are:

• Ethical Concerns: The use of CRISPR in gene editing raises significant ethical issues, including concerns about genetic engineering, its long-term consequences, and the creation of "designer babies." Addressing these concerns will be crucial for future ethical practices in fields like tissue engineering.
• Intellectual Property Issues: The CRISPR market is entangled in competing patent disputes between multiple institutions and biotech companies. Disagreements over intellectual property rights can hinder cooperation and stifle creativity, creating challenges for the market.
• Technical Limitations: While CRISPR technology is highly effective, it still faces challenges such as off-target effects and limitations in delivery methods. Eliminating these drawbacks is essential, particularly for therapeutic applications, though further improvements are needed.

These challenges pose risks to the CRISPR market's growth and the rate of innovation. Overcoming legal, social, and procedural barriers will be essential for realizing the benefits of CRISPR technology with minimal associated risks.

List of Clustered Regularly Interspaced Short Palindromic Repeat Technology Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies clustered regularly interspaced short palindromic repeat technology companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the clustered regularly interspaced short palindromic repeat technology companies profiled in this report include-

• Thermo Fisher Scientific
• Merck
• Agilent Technologies
• Genscript Biotech
• CRISPR Therapeutics
• Editas Medicine
• Intellia Therapeutics
• Beam Therapeutics
• Caribou Biosciences
• Lonza

Clustered Regularly Interspaced Short Palindromic Repeat Technology by Segment

The study includes a forecast for the global clustered regularly interspaced short palindromic repeat technology market by type, application, end use, and region.

Clustered Regularly Interspaced Short Palindromic Repeat Technology Market by Type [Analysis by Value from 2019 to 2031]:

• Product
• Service
• Others

Clustered Regularly Interspaced Short Palindromic Repeat Technology Market by Application [Analysis by Value from 2019 to 2031]:

• Drug Discovery & Development
• Agriculture
• Others

Clustered Regularly Interspaced Short Palindromic Repeat Technology Market by End Use [Analysis by Value from 2019 to 2031]:

• Pharmaceutical & Biotechnology Company
• Academic & Research Institute
• Others

Clustered Regularly Interspaced Short Palindromic Repeat Technology Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Clustered Regularly Interspaced Short Palindromic Repeat Technology Market

The clustered regularly interspaced short palindromic repeat (CRISPR) market has undergone rapid changes in recent years, particularly in major global markets such as the USA, China, Germany, India, and Japan. These countries are experiencing new trends, such as increased research funding, regulatory changes, and the adoption of new therapies, which are creating opportunities in this ever-evolving industry.

• United States: In the United States, CRISPR research is advancing significantly, with new developments, including approved CRISPR therapies for clinical use in treating inherited genetic disorders. Companies like Referral Therapeutics are partnering with Aristech Corporations and Miyuki Biopharma to advance gene therapies. Additionally, collaborations between universities and the pharmaceutical industry are becoming more active, driving progress in CRISPR techniques and strategies.
• China: China has positioned itself as a global leader in CRISPR research, actively seeking funding and developing gene engineering technologies. The country is also funding agricultural CRISPR innovations aimed at improving crop quality and production. Chinese biotech firms are conducting clinical trials for CRISPR-based therapies targeting various cancers and genetic disorders, while regulatory policies are becoming more flexible and conducive to CRISPR development.
• Germany: Germany is one of the European countries leading CRISPR research, with several research institutions focusing on gene editing applications. There has been a notable increase in investment in CRISPR projects, particularly in major export crops and health care reforms. Efforts are underway to develop more accurate and efficient CRISPR delivery systems. Additionally, Germany is engaging the public in discussions about the ethics of CRISPR technology, ensuring that ethics and science progress together.
• India: India is making significant strides in the CRISPR market, focusing on agricultural advancements and cost-effective healthcare solutions. Recent developments include partnerships between startups and research institutions to improve crop resilience. Regulators are beginning to establish frameworks for gene editing technologies, which is vital for promoting development. Educational programs are also being introduced to raise awareness of the positive aspects of CRISPR technologies and their potential impacts.
• Japan: Healthcare and therapeutic applications dominate Japan's CRISPR market, with recent progress in developing CRISPR-based therapies for rare genetic diseases. Japanese researchers are collaborating internationally to accelerate CRISPR technology advancements. The government is also funding proposals focused on precision medicine, strengthening the country's position in genomics and biotechnology.

Features of the Global Clustered Regularly Interspaced Short Palindromic Repeat Technology Market

Market Size Estimates: Clustered regularly interspaced short palindromic repeat technology market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecasts (2025 to 2031) by various segments and regions.

Segmentation Analysis: Clustered regularly interspaced short palindromic repeat technology market size by type, application, end use, and region in terms of value ($B).

Regional Analysis: Clustered regularly interspaced short palindromic repeat technology market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, application, end use, and regions for the clustered regularly interspaced short palindromic repeat technology market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the clustered regularly interspaced short palindromic repeat technology market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the clustered regularly interspaced short palindromic repeat technology market by type (product, service, and others), application (drug discovery & development, agriculture, and others), end use (pharmaceutical & biotechnology company, academic & research institute, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Clustered Regularly Interspaced Short Palindromic Repeat Technology Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Clustered Regularly Interspaced Short Palindromic Repeat Technology Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Clustered Regularly Interspaced Short Palindromic Repeat Technology Market by Type
  • 3.3.1: Product
  • 3.3.2: Service
  • 3.3.3: Others
• 3.4: Global Clustered Regularly Interspaced Short Palindromic Repeat Technology Market by Application
  • 3.4.1: Drug Discovery & Development
  • 3.4.2: Agriculture
  • 3.4.3: Others
• 3.5: Global Clustered Regularly Interspaced Short Palindromic Repeat Technology Market by End Use
  • 3.5.1: Pharmaceutical & Biotechnology Company
  • 3.5.2: Academic & Research Institute
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Clustered Regularly Interspaced Short Palindromic Repeat Technology Market by Region
• 4.2: North American Clustered Regularly Interspaced Short Palindromic Repeat Technology Market
  • 4.2.1: North American Market by Type: Product, Service, and Others
  • 4.2.2: North American Market by End Use: Pharmaceutical & Biotechnology Company, Academic & Research Institute, and Others
• 4.3: European Clustered Regularly Interspaced Short Palindromic Repeat Technology Market
  • 4.3.1: European Market by Type: Product, Service, and Others
  • 4.3.2: European Market by End Use: Pharmaceutical & Biotechnology Company, Academic & Research Institute, and Others
• 4.4: APAC Clustered Regularly Interspaced Short Palindromic Repeat Technology Market
  • 4.4.1: APAC Market by Type: Product, Service, and Others
  • 4.4.2: APAC Market by End Use: Pharmaceutical & Biotechnology Company, Academic & Research Institute, and Others
• 4.5: ROW Clustered Regularly Interspaced Short Palindromic Repeat Technology Market
  • 4.5.1: ROW Market by Type: Product, Service, and Others
  • 4.5.2: ROW Market by End Use: Pharmaceutical & Biotechnology Company, Academic & Research Institute, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Clustered Regularly Interspaced Short Palindromic Repeat Technology Market by Type
  • 6.1.2: Growth Opportunities for the Global Clustered Regularly Interspaced Short Palindromic Repeat Technology Market by Application
  • 6.1.3: Growth Opportunities for the Global Clustered Regularly Interspaced Short Palindromic Repeat Technology Market by End Use
  • 6.1.4: Growth Opportunities for the Global Clustered Regularly Interspaced Short Palindromic Repeat Technology Market by Region
• 6.2: Emerging Trends in the Global Clustered Regularly Interspaced Short Palindromic Repeat Technology Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Clustered Regularly Interspaced Short Palindromic Repeat Technology Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Clustered Regularly Interspaced Short Palindromic Repeat Technology Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Thermo Fisher Scientific
• 7.2: Merck
• 7.3: Agilent Technologies
• 7.4: Genscript Biotech
• 7.5: CRISPR Therapeutics
• 7.6: Editas Medicine
• 7.7: Intellia Therapeutics
• 7.8: Beam Therapeutics
• 7.9: Caribou Biosciences
• 7.10: Lonza